Virax Biolabs Group Ltd

VRAX · XNAS

CIK 1885827fmd_1E7EZG81W952JV1AC4G50H6GM8Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Apr 01, 2020 to Mar 31, 2026, 6 periods

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).